Advertisement

Topics

Azitra Inc. Company Profile

20:45 EDT 25th May 2018 | BioPortfolio


News Articles [3 Associated News Articles listed on BioPortfolio]

Azitra secures $2.15 million convertible debt financing led jointly by Bios Partners and Connecticut Innovations

The post Azitra secures $2.15 million convertible debt financing led jointly by Bios Partners and Connecticut Innovations appeared first on SynBioBeta.

CORRECTING and REPLACING Azitra Secures $2.15 Million Convertible Debt Financing Led Jointly by Bios Partners and Connecticut Innovations

Please replace the release with the following corrected version due to multiple revisions. The corrected release reads:  AZITRA SECURES $2.15 MILLION CON...

Azitra Secures $2.15 Million Convertible Debt Financing Led Jointly by Bios Ventures and Connecticut Innovations

Azitra Inc. today announced that it has secured $2.15 million in convertible debt financing to support advancement of the company’s pipeline of dermatology and skin care product...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Azitra, Inc.

Azitra, Inc. is a preclinical company that aims to harness the power of the microbiome on the skin. Since 2014, the company has been working with world-leading scientists in derma...

Azitra Inc.

More Information about "Azitra Inc." on BioPortfolio

We have published hundreds of Azitra Inc. news stories on BioPortfolio along with dozens of Azitra Inc. Clinical Trials and PubMed Articles about Azitra Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Azitra Inc. Companies in our database. You can also find out about relevant Azitra Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record